Product
Latiglutenase
Aliases
IMGX003
2 clinical trials
1 indication
Indication
Celiac DiseaseClinical trial
Prospective, Double-Blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of Latiglutenase Treatment in Type 1 Diabetes Patients With Celiac Disease While Undergoing Periodic Gluten ExposureStatus: Terminated, Estimated PCD: 2022-12-19
Clinical trial
Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of Latiglutenase Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet While Undergoing Periodic Gluten ExposureStatus: Active (not recruiting), Estimated PCD: 2023-12-01